CBD shows promise for emotional health in HIV patients
NCT ID NCT05832281
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether synthetic cannabidiol (CBD) could help people living with HIV who have a condition called alexithymia, which makes it hard to recognize and describe emotions. Participants took either CBD or a placebo for 4 weeks. The goal was to see if CBD could improve emotional awareness and reduce inflammation. Only 5 people were enrolled before the study was terminated, so results are very preliminary.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
synthetic cannabidiol (CBD)
What this could lead to
If it works, CBD could offer a way to help people with HIV who struggle to identify emotions, potentially improving their mental and physical health.
What could go wrong
This was a very small, early-phase study that was terminated early, so results are limited. CBD may not work for everyone, and side effects are possible.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
HIV Neurobehavioral Research Center/Center for Medicinal Cannabis Research
San Diego, California, 92103, United States